A cheap, widely available steroid called dexamethasone reduced deaths by up to one third in severely ill hospitalized patients.
Researchers in England say they have the first evidence that a drug can improve COVID-19 survival:
The drug was given either orally or through an IV. After 28 days, it had reduced deaths by 35% in patients who needed treatment with breathing machines and by 20% in those only needing supplemental oxygen. It did not appear to help less ill patients.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
COVID-19 cases haven't deterred college football's quest to return, but when would they?As players return to campuses and the season looks more likely, positive COVID-19 tests are a reminder of the challenges college football still faces.
続きを読む »
Florida Hits Biggest Daily COVID-19 Jump As It Gears Up For GOP ConventionFlorida coronavirus cases jumped 35% Saturday over the previous day, smashing a single-day record just as state officials are gearing up to host thousands of visitors for major events of the Republican National Convention in August
続きを読む »
UK COVID-19 death toll rises by 36, lowest daily tally during lockdownThe United Kingdom's death toll from confirmed cases of COVID-19 rose by 36 to 41,698 as of 1600 GMT on June 13, government data showed on Sunday.
続きを読む »
Medical bias: From pain pills to COVID-19, racial discrimination in health care festersWhether it's unconscious, explicit, institutional or research bias, discrimination in the health care system contributes to the stark disparities seen in how COVID-19 sickens and kills patients of color.
続きを読む »
Un cluster de Covid-19 identifié en Haute-GaronneUn cluster de Covid-19 a été identifié autour de Toulouse, en Haute-Garonne a annoncé samedi soir l'Agence régionale de santé d'Occitanie qui fait état de 16 personnes contaminées sur un groupe d'une cinquantaine de personnes.
続きを読む »